Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Healthcare Cannabis
Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Canopy Growth Corp > “Full legalization” is not required
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(500)
•••
Comment by Homestretch4meon Feb 26, 2021 2:02pm
118 Views
Post# 32672686

RE:RE:RE:RE:RE:RE:RE:“Full legalization” is not required

RE:RE:RE:RE:RE:RE:RE:“Full legalization” is not required Oh my God you're an id!ot. I haven't ignored anyone in a long time but I have my hands full with Starcrapper and Lou(ser). You have no clue what you are talking about so there is no point debating you. There are so many things in your posts that are just plain wrong or you are purposely lying. Say hi to all the other losers on iggie mountain.
Sampic wrote: Homestretch you obviously are not in business and have never seen how complicated contracts are Canopy can kill this Acerage deal 100 percent or dilute it to a point it doesn't make sense for acrg forcing them to back out.You think Acrg would have taken 2.5 billion less if they had a choice?


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities